• 1
    McGee DC, Gould MK. Preventing complications of central venous catheterisation. N Engl J Med 2003; 348: 112333.
  • 2
    Horattas MC, Wright DJ, Fenton AH, Evans DM, Oddi MA, Kamienski RW, Shields EF. Changing concepts of deep venous thrombosis of the upper extremity – report of a series and review of the literature. Surgery 1988; 104: 5617.
  • 3
    Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S400S.
  • 4
    Verso M, Agnelli G. Venous thromboembolism associated with long-tem use of central venous catheters in cancer patients. J Clin Oncol 2003; 21: 366575.
  • 5
    Haire WD, Lieberman RP, Lund GB, Edney JA, Kessinger A, Armitage JO. Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters. Bone Marrow Transplant 1991; 7: 579.
  • 6
    Van Rooden CJ, Rosendaal FR, Meinders AE, Van Oostayen JA, Van Der Meer FJ, Huisman MV. The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Haematologica 2004; 89: 2016.
  • 7
    Dollery CM, Sullivan ID, Bauraind O, Bull C, Milla PJ. Thrombosis and embolism in long-term central venous access for parenteral nutrition. Lancet 1994; 344: 10435.
  • 8
    Balestreri L, De Cicco M, Matovic M, Coran F, Morassut S. Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: a phlebographic study. Eur J Radiol 1995; 20: 10811.
  • 9
    Knudson GJ, Wiedmeyer DA, Erickson SJ, Foley WD, Lawson TL, Mewissen MW, Lipchik EO. Color Doppler sonographic imaging in the assessment of upper-extremity deep venous thrombosis. AJR Am J Roentgenol 1990; 154: 399403.
  • 10
    Prandoni P, Polistena P, Bernardi E, Cogo A, Casara D, Verlato F, Angelini F, Simioni P, Signorini GP, Benedetti L, Girolami A. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med 1997; 157: 5762.
  • 11
    Baarslag HJ, Van Beek EJ, Koopman MM, Reekers JA. Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann Intern Med 2002; 136: 86572.
  • 12
    Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 13444.
  • 13
    Hirsh J, Lee AY. How we diagnose and treat deep vein thrombosis. Blood 2002; 99: 310210.
  • 14
    Baarslag HJ, Van Beek EJ, Tijssen JG, van Delden OM, Bakker AJ, Reekers JA. Deep vein thrombosis of the upper extremity: intra- and interobserver study of digital subtraction venography. Eur Radiol 2003; 13: 2515.
  • 15
    Baxter GM, Kincaid W, Jeffrey RF, Millar GM, Porteous C, Morley P. Comparison of colour Doppler ultrasound with venography in the diagnosis of axillary and subclavian vein thrombosis. Br J Radiol 1991; 64: 77781.
  • 16
    Koksoy C, Kuzu A, Kutlay J, Erden I, Ozcan H, Ergin K. The diagnostic value of colour Doppler ultrasound in central venous catheter related thrombosis. Clin Radiol 1995; 50: 6879.
  • 17
    Haire WD, Lynch TG, Lund GB, Lieberman RP, Edney JA. Limitations of magnetic resonance imaging and ultrasound-directed (duplex) scanning in the diagnosis of subclavian vein thrombosis. J Vasc Surg 1991; 13: 3917.
  • 18
    Bonnet F, Loriferne JF, Texier JP, Texier M, Salvat A, Vasile N. Evaluation of Doppler examination for diagnosis of catheter-related deep vein thrombosis. Intensive Care Med 1989; 15: 23840.
  • 19
    Mustafa BO, Rathbun SW, Whitsett TL, Raskob GE. Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review. Arch Intern Med 2002; 162: 4014.
  • 20
    Muhm M, Sunder-Plassmann G, Apsner R, Kritzinger M, Hiesmayr M, Druml W. Supraclavicular approach to the subclavian/innominate vein for large-bore central venous catheters. Am J Kidney Dis 1997; 30: 8028.
  • 21
    Lokich JJ, Becker B. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 1983; 52: 15869.
  • 22
    Chastre J, Cornud F, Bouchama A, Viau F, Benacerraf R, Gibert C. Thrombosis as a complication of pulmonary-artery catheterization via the internal jugular vein: prospective evaluation by phlebography. N Engl J Med 1982; 306: 27881.
  • 23
    Durbec O, Viviand X, Potie F, Vialet R, Albanese J, Martin C. A prospective evaluation of the use of femoral venous catheters in critically ill adults. Crit Care Med 1997; 25: 19869.
  • 24
    Timsit JF, Farkas JC, Boyer JM, Martin JB, Misset B, Renaud B, Carlet J. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 1998; 114: 20713.
  • 25
    Wu X, Studer W, Skarvan K, Seeberger MD. High incidence of intravenous thrombi after short-term central venous catheterization of the internal jugular vein. J Clin Anesth 1999; 11: 4825.
  • 26
    Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest 2000; 117: 17883.
  • 27
    Martin C, Viviand X, Saux P, Gouin F. Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein. Crit Care Med 1999; 27: 26269.
  • 28
    Stoney WS, Addlestone RB, Alford WC Jr, Burrus GR, Frist RA, Thomas CS Jr. The incidence of venous thrombosis following long-term transvenous pacing. Ann Thorac Surg 1976; 22: 16670.
  • 29
    Lin LJ, Lin JL, Tsai WC, Teng JK, Tsai LM, Chen JH. Venous access thrombosis detected by transcutaneous vascular ultrasound in patients with single-polyurethane-lead permanent pacemaker. Pacing Clin Electrophysiol 1998; 21: 396400.
  • 30
    Goto Y, Abe T, Sekine S, Sakurada T. Long-term thrombosis after transvenous permanent pacemaker implantation. Pacing Clin Electrophysiol 1998; 21: 11925.
  • 31
    Antonelli D, Turgeman Y, Kaveh Z, Artoul S, Rosenfeld T. Short-term thrombosis after transvenous permanent pacemaker insertion. Pacing Clin Electrophysiol 1989; 12: 2802.
  • 32
    Van Rooden CJ, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Clin Electrophysiol 2004; 15: 125862.
  • 33
    Valerio D, Hussey JK, Smith FW. Central vein thrombosis associated with intravenous feeding – a prospective study. JPEN J Parenter Enteral Nutr 1981; 5: 2402.
  • 34
    Brismar B, Hardstedt C, Jacobson S, Kager L, Malmborg AS. Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapy. Arch Surg 1982; 117: 11969.
  • 35
    Bozzetti F, Scarpa D, Terno G, Scotti A, Ammatuna M, Bonalumi MG, Ceglia E. Subclavian venous thrombosis due to indwelling catheters: a prospective study on 52 patients. JPEN J Parenter Enteral Nutr 1983; 7: 5602.
  • 36
    Pottecher T, Forrler M, Picardat P, Krause D, Bellocq JP, Otteni JC. Thrombogenicity of central venous catheters: prospective study of polyethylene, silicone and polyurethane catheters with phlebography or post-mortem examination. Eur J Anaesthesiol 1984; 1: 3615.
  • 37
    De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S, Testa V. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 1997; 86: 10113.
  • 38
    Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, Rotmensz N, Robertson C, Bellomi M, Andreoni B. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 2001; 92: 120412.
  • 39
    Luciani A, Clement O, Halimi P, Goudot D, Portier F, Bassot V, Luciani JA, Avan P, Frija G, Bonfils P. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology 2001; 220: 65560.
  • 40
    Harter C, Salwender HJ, Bach A, Egerer G, Goldschmidt H, Ho AD. Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: a prospective comparison of silver-coated and uncoated catheters. Cancer 2002; 94: 24551.
  • 41
    Lordick F, Hentrich M, Decker T, Hennig M, Pohlmann H, Hartenstein R, Peschel C. Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational study. Br J Haematol 2003; 120: 10738.
  • 42
    Van Rooden CJ, Rosendaal FR, Barge RM, Van Oostayen JA, Van Der Meer FJ, Meinders AE, Huisman MV. Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound. Br J Haematol 2003; 123: 50712.
  • 43
    Nowak-Gottl U, Dubbers A, Kececioglu D, Koch HG, Kotthoff S, Runde J, Vielhaber H. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr 1997; 131: 60812.
  • 44
    Beck C, Dubois J, Grignon A, Lacroix J, David M. Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: a prospective study. J Pediatr 1998; 133: 23741.
  • 45
    Ljung R. Central venous catheters in children with haemophilia. Blood Rev 2004; 18: 93100.
  • 46
    Fijnheer R, Paijmans B, Verdonck LF, Nieuwenhuis HK, Roest M, Dekker AW. Factor V Leiden in central venous catheter-associated thrombosis. Br J Haematol 2002; 118: 26770.
  • 47
    Di Micco P, Niglio A, De Renzo A, Lucania A, Di Fiore R, Scudiero O, Castaldo G. Congenital and acquired thrombotic risk factors in lymphoma patients bearing upper extremities deep venous thrombosis: a preliminary report. J Transl Med 2004; 2: 7.
  • 48
    Mandala M, Curigliano G, Bucciarelli P, Ferretti G, Mannucci PM, Colleoni M, Ventura A, Peruzzotti G, Severi G, Pelicci PG, Biffi R, Orsi F, Cinieri S, Goldhirsch A. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Ann Oncol 2004; 15: 5903.
  • 49
    Riordan M, Weiden PL. Factor V Leiden mutation does not account for central venous catheter-related thrombosis. Am J Hematol 1998; 58: 1502.
  • 50
    Wermes C, von Depka P, Lichtinghagen R, Barthels M, Welte K, Sykora KW. Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters. Eur J Pediatr 1999; 158: S143146.
  • 51
    Knofler R, Siegert E, Lauterbach I, Taut-Sack H, Siegert G, Gehrisch S, Muller D, Rupprecht E, Kabus M. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy – impact of central venous lines. Eur J Pediatr 1999; 158: S14750.
  • 52
    De Cicco M, Matovic M, Balestreri L, De A, V, Fracasso A, Morassut S, Coran F, Babare R, Buonadonna A, Testa V. Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients. Thromb Res 1995; 78: 12737.
  • 53
    Gould JR, Carloss HW, Skinner WL. Groshong catheter-associated subclavian venous thrombosis. Am J Med 1993; 95: 41923.
  • 54
    Borow M, Crowley JG. Evaluation of central venous catheter thrombogenicity. Acta Anaesthesiol Scand 1985; 81: 5964.
  • 55
    Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995; 13: 2338.
  • 56
    Merrer J, De Jonghe B, Golliot F, Lefrant JY, Raffy B, Barre E, Rigaud JP, Casciani D, Misset B, Bosquet C, Outin H, Brun-Buisson C, Nitenberg G. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001; 286: 7007.
  • 57
    Trottier SJ, Veremakis C, O'Brien J, Auer AI. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. Crit Care Med 1995; 23: 529.
  • 58
    Male C, Chait P, Andrew M, Hanna K, Julian J, Mitchell L. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood 2003; 101: 42738.
  • 59
    Brismar B, Hardstedt C, Malmborg AS. Bacteriology and phlebography in catheterization for parenteral nutrition. A prospective study. Acta Chir Scand 1980; 146: 1159.
  • 60
    Monreal M, Raventos A, Lerma R, Ruiz J, Lafoz E, Alastrue A, Llamazares JF. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines – a prospective study. Thromb Haemost 1994; 72: 54850.
  • 61
    Frank DA, Meuse J, Hirsch D, Ibrahim JG, van den Abbeele AD. The treatment and outcome of cancer patients with thromboses on central venous catheters. J Thromb Thrombolysis 2000; 10: 2715.
  • 62
    Hingorani A, Ascher E, Lorenson E, DePippo P, Salles-Cunha S, Scheinman M, Yorkovich W, Hanson J. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg 1997; 26: 85360.
  • 63
    Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994; 271: 10146.
  • 64
    Van Rooden CJ, Schippers EF, Barge RMY, Rosendaal FR, Guiot HFL, Van der Meer FJM, Meinders AE, Huisman MV. Infectious complications of central venous catheters increase the risk of catheter related thrombosis in hematology patients: a prospective study. J Clin Oncology 2005; 23: 26552660.
  • 65
    Herrmann M, Vaudaux PE, Pittet D, Auckenthaler R, Lew PD, Schumacher-Perdreau F, Peters G, Waldvogel FA. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988; 158: 693701.
  • 66
    Vaudaux P, Pittet D, Haeberli A, Huggler E, Nydegger UE, Lew DP, Waldvogel FA. Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. J Infect Dis 1989; 160: 86575.
  • 67
    Mokrzycki MH, Jean-Jerome K, Rush H, Zdunek MP, Rosenberg SO. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 2001, 59, 19351942.
  • 68
    Cetinkaya R, Odabas AR, Unlu Y, Selcuk Y, Ates A, Ceviz M. Using cuffed and tunnelled central venous catheters as permanent vascular access for hemodialysis: a prospective study. Renal Failure 2003, 25, 431438.
  • 69
    Nightingale CE, Norman A, Cunningham D, Young J, Webb A, Filshie J. A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy. Eur J Cancer 1997; 33: 398403.
  • 70
    Moureau N, Poole S, Murdock MA, Gray SM, Semba CP. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol 2002; 13: 100916.
  • 71
    Egermayer P. The effects of heparin and oral anticoagulants on thrombus propagation and prevention of the postphlebitic syndrome: a critical review of the literature. Prog Cardiovasc Dis 2001; 44: 6980.
  • 72
    Hicken GJ, Ameli FM. Management of subclavian-axillary vein thrombosis: a review. Can J Surg 1998; 41: 1325.
  • 73
    Monagle P, Adams M, Mahoney M, Ali K, Barnard D, Bernstein M, Brisson L, David M, Desai S, Scully MF, Halton J, Israels S, Jardine L, Leaker M, McCusker P, Silva M, Wu J, Anderson R, Andrew M, Massicotte MP. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 7636.
  • 74
    Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, Greco FA, Huberman M, Moore C. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112: 4238.
  • 75
    Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, Abad A. Upper extremity deep venous thrombosis in cancer patients with venous access devices – prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75: 2513.
  • 76
    Abdelkefi A, Ben Othman T, Kammoun L, Chelli M, Romdhane NB, Kriaa A, Ladeb S, Torjman L, Lakhal A, Achour W, Ben Hassen A, Hsairi M, Ladeb F, Ben Abdeladhim A. Prevention of central line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomised controlled trail. Thromb Hamost 2004; 92: 65461.
  • 77
    Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, Chan AK, Andrew M. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res 2003; 109: 1018.
  • 78
    Pierce CM, Wade A, Mok Q. Heparin bonded central venous lines reduce thrombostic and infective complications in critically ill children. Intensive Care Med 2000; 26: 96772.
  • 79
    Macoviak JA, Melnik G, McLean G, Lunderquist A, Singer R, Forlaw L, Rombeau JL. The effect of low-dose heparin on the prevention of venous thrombosis in patients receiving short-term parenteral nutrition. Curr Surg 1984; 41: 98100.
  • 80
    Ruggiero RP, Aisenstein TJ. Central catheter fibrin sleeve – heparin effect. JPEN J Parenter Enteral Nutr 1983; 7: 2703.
  • 81
    Fabri PJ, Mirtallo JM, Ruberg RL, Kudsk KA, Denning DA, Ellison EC, Schaffer P. Incidence and prevention of thrombosis of the subclavian vein during total parenteral nutrition. Surg Gynecol Obstet 1982; 155: 23840.
  • 82
    Fabri PJ, Mirtallo JM, Ebbert ML, Kudsk KA, Powell C, Ruberg RL. Clinical effect of nonthrombotic total parenteral nutrition catheters. JPEN J Parenter Enteral Nutr 1984; 8: 7057.
  • 83
    Reichardt P, Kretzschmar A, Biakhov M. A phase III randomised, double-blind, placebo controlled study evaluating the efficacy and safety of daily low-molecular-weight heparin (daleparin sodium, fragmin) in preventing catheter-related complications (CRCs) in cancer patients with central venous catheters (CVCs). Proc Am Soc Clin Oncol 2002; 21: 361a.
  • 84
    Heaton DC, Han DY, Inder A. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J 2002; 32: 848.
  • 85
    Anderson D, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Couban S. A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer. J Thromb Haemost 2003; 1: (suppl 1) A1982.
  • 86
    Boraks P, Seale J, Price J, Bass G, Ethell M, Keeling D, Mahendra P, Baglin T, Marcus R. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998; 101: 4836.
  • 87
    Lagro SW, Verdonck LF, Borel RI, Dekker AW. No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients. Bone Marrow Transplant 2000; 26: 11036.
  • 88
    Carr KM, Rabinowitz I. Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors. J Clin Oncol 2000; 18: 36657.
  • 89
    Van Rooden CJ, Monraats PS, Kettenis IM, Rosendaal FR, Huisman MV. Low physician compliance of prescribing anticoagulant prophylaxis in patients with solid tumor or hematological malignancies and central vein catheters. J Thromb Haemost 2003; 1: 18423.
  • 90
    Masci G, Magagnoli M, Zucali PA, Castagna L, Carnaghi C, Sarina B, Pedicini V, Fallini M, Santoro A. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy? J Clin Oncol 2003; 21: 7369.
  • 91
    Savage KJ, Wells PS, Schulz V, Goudie D, Morrow B, Cruickshank M, Kovacs MJ. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity. Thromb Haemost 1999; 82: 100810.
  • 92
    Karabay O, Yetkin U, Onal H. Upper extremity deep vein thrombosis: clinical and treatment characteristics. J Int Med Res 2004; 32: 429435.
  • 93
    Gupta AA, Leaker M, Andrew M, Massicotte P, Liu L, Benson LN, McCrindle BW. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr 2001; 139: 6828.
  • 94
    Schindler J, Bona RD, Chen HH, Feingold JM, Edwards RL, Tutschka PJ, Bilgrami S. Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue. Clin Appl Thromb Hemost 1999; 5: 259.
  • 95
    Rodenhuis S, van't Hek LG, Vlasveld LT, Kroger R, Dubbelman R, van Tol RG. Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator. Thorax 1993; 48: 5589.
  • 96
    Fraschini G, Jadeja J, Lawson M, Holmes FA, Carrasco HC, Wallace S. Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. J Clin Oncol 1987; 5: 6728.
  • 97
    Sabeti S, Schillinger M, Mlekusch W, Haumer M, Ahmadi R, Minar E. Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis. Thromb Res 2002; 108: 27985.
  • 98
    Ponec D, Irwin D, Haire WD, Hill PA, Li X, McCluskey ER. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial – the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol 2001; 12: 9515.
  • 99
    Semba CP, Deitcher SR, Li X, Resnansky L, Tu T, McCluskey ER. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients. J Vasc Interv Radiol 2002; 13: 1199205.
  • 100
    Twardowski ZJ. High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters. Am J Kidney Dis 1998; 31: 8417.
  • 101
    Monturo CA, Dickerson RN, Mullen JL. Efficacy of thrombolytic therapy for occlusion of long-term catheters. JPEN J Parenter Enteral Nutr 1990; 14: 3124.